Our News on Newswise

Newswise: CoVIClogo.png

La Jolla Institute for Immunology to host coronavirus immunotherapy clearinghouse

La Jolla Institute for Immunology (LJI) has been awarded a $1.73 million grant by the Bill & Melinda Gates Foundation to establish a Coronavirus Immunotherapy Consortium (CoVIC) as part of the foundation’s global efforts to stem the tide of the...
26-Mar-2020 7:10 PM EDT Add to Favorites

Newswise: Graphicalabstract.png

LJI scientists identify potential targets for immune responses to novel coronavirus

Publishing in the March 16, 2020, online issue of Host, Cell and Microbe, a team of researchers at La Jolla Institute for Immunology, in collaboration with researchers at the J. Craig Venter Institute, provides the first analysis of potential...
11-Mar-2020 6:15 PM EDT Add to Favorites

Newswise: Yuanetal.png

Cellular culprit suspected of pushing dengue fever from bad to worse is cleared by advanced transcriptomics

No one knows what makes a mild dengue viral infection morph into a severe and sometimes deadly dengue hemorrhagic fever/dengue shock syndrome. Experts previously believed the likely cause was ramped up activity of T cells, which can massively boost...
19-Dec-2019 3:05 PM EST Add to Favorites

Newswise: 2019LJIexterior.jpg

La Jolla Institute for Immunology acquires Berkeley Lights Beacon® platform

La Jolla Institute for Immunology (LJI) is placing their confidence in Berkeley Lights’ Beacon® Optofluidic Platform and B cell antibody discovery workflow to accelerate the discovery of rare and lifesaving antibodies for the treatment of...
9-Dec-2019 1:00 AM EST Add to Favorites

Newswise: Bcellssecretingabs.jpg

LJI researchers reveal unexpected versatility of an ancient DNA repair factor

New work from the lab of La Jolla Institute for Immunology (LJI) investigator Anjana Rao, Ph.D., reveals a previously unrecognized activity for a highly conserved DNA repair factor. The study reports that mouse lymphocytes engineered to lack that...
26-Nov-2019 4:35 PM EST Add to Favorites

Newswise: seqster_logo_RGB.png

Seqster Signs 3-year License Agreement of SRP™ to La Jolla Institute of Immunology for Asthma Study

Seqster, the award-winning SaaS-based technology platform enabling consumer-centered health data management, today announced a 3-year licensing deal and partnership with La Jolla Institute of Immunology (LJI) to support the execution of a $6.9...
22-Oct-2019 11:30 AM EDT Add to Favorites

Newswise: highresversion2.jpg

Lassa Virus’ Soft Spot Revealed

A new study, led by researchers at La Jolla Institute for Immunology (LJI), identified and then reverse engineered the molecular properties shared by antibodies that are particularly efficient at inactivating or “neutralizing” Lassa virus...
5-Aug-2019 8:05 AM EDT Add to Favorites

Newswise: RaoPRillustration-02.png

TET proteins: double agents in DNA methylation prevent catastrophic cancer

In their latest study, published in this week’s online issue of Proceedings of the National Academy of Sciences, researchers at La Jolla Institute for Immunology (LJI), reveal how the finely tuned balance between DNA methylation and demethylation...
24-Jul-2019 2:45 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: EricaSaphire-139_p.jpg

Expert available to discuss Lassa virus and antibody therapies against the virus

26-Nov-2019 10:40 AM EST

Newswise: 2018Dr.MatthiasvonHerrath.jpg

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and...
12-Dec-2018 11:05 AM EST

See All Experts

Our YouTube Videos

About

The La Jolla Institute for Immunology is dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand our understanding of how the immune system works and to discover the causes of immune system disorders. The knowledge gained through our biomedical research can, in turn lead to the prevention, treatment and cure of a wide range of human diseases.

Experts

Contacts

Gina Kirchweger
Chief Communications Officer
allergy immunology

gina@lji.org

858-752-6640

Jenna Hambrick
Digital Strategist

jhambrick@lji.org

858.752.6645

Twitter

close
1.05264